Pure Financial Advisors’s Novo Nordisk NVO Stock Holding History

Pure Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$804K	Buy	16,779 +6,857	+69%	+$295K	0.01%	275
2026 Q1	$365K	Buy	9,922 +5,549	+127%	+$263K	0.01%	408
2025 Q4	$223K	Sell	4,373 -908	-17%	-$46.4K	﹤0.01%	488
2025 Q3	$293K	Buy	5,281 +1,780	+51%	+$104K	﹤0.01%	400
2025 Q2	$242K	Buy	+3,501	New	+$238K	﹤0.01%	423

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Pure Financial Advisors's NVO Position: Q2 2026 in Review

Pure Financial Advisors increased its Novo Nordisk (NVO) stake by 69% in Q2 2026, buying an estimated $295K and bringing the position to 16,779 shares worth $804K. The position accounts for 0.01% of the portfolio, ranked #275.

Pure Financial Advisors first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Pure Financial Advisors held 16,779 shares of Novo Nordisk worth $804K as of Q2 2026.
Pure Financial Advisors bought 6,857 Novo Nordisk shares in Q2 2026, an estimated $295K.
Novo Nordisk made up 0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #275 holding.
Pure Financial Advisors first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.